F. Hoffmann-La Roche Ltd (secondary packaging, quality control testing, batch release)

Ukraine

All drugs from this manufacturer

  • MABTHERA

    The drug is used to treat certain types of non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, as well as granulomatosis with polyangiitis and microscopic polyangiitis.

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    rituximab 10 mg/ml

    ATC: L01FA01